ZFTA::NCOA1/2-Rearranged Epithelioid Mesenchymal Tumor—A Phenotypically Distinct Myoepithelial-Like Neoplasm Epigenetically Overlapping With Chondroid Lipoma
Modern Pathology · 2026
DOI: 10.1016/j.modpat.2025.100939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2026. Verfasst von Raheel Rizwan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio. Hauptthemen laut MEDLINE: Lipoma, Nuclear Receptor Coactivator 2, Soft Tissue Neoplasms. Die Arbeit nennt 23 Literaturangaben. Gefördert von: U.S. Department of Defense, Cleveland Clinic, European Commission.
Abstract (Originalsprache)
ZFTA (formerly C11orf95) gene rearrangements are recurrent in rare tumors of the central nervous system, such as ependymomas (mostly ZFTA::RELA) and soft tissue tumors, such as chondroid lipomas (ZFTA::MRTFB). To date, among mesenchymal tumors, the ZFTA::NCOA1 fusion has only been reported in a single case of chondroid lipoma. We describe 5 distinct soft tissue tumors harboring ZFTA::NCOA1/2 fusions. The tumors arose from 2 females and 3 males with a median age of 31 years (range, 30-72). All tumors were well circumscribed involving the deep (4 cases) or superficial (1 case) soft tissue of the proximal limbs with a median greatest dimension of 4.2 cm (range, 1.7-6.0). Histologically, they displayed lobulated architecture and were composed of monotonous epithelioid-to-plasmacytoid cells arranged in cords, chains, and nests within myxohyaline or sclerosed stroma. Focal loose myxoid reticulate areas and prominent dilated and hyalinized blood vessels were present. One tumor showed focal spindle cells, whereas another demonstrated necrosis and atypical mitotic figures. Definitive adipocytic, lipoblastic, or clear-cell features were absent, except in 1 case. Immunohistochemistry was nonspecific without any consistent lineage-defining marker expression. Targeted RNA sequencing confirmed ZFTA::NCOA1 fusions in 3 and ZFTA::NCOA2 fusion in 2 cases. DNA methylation profiling, available in 4 cases, demonstrated a shared epigenetic profile with chondroid lipoma but not other tumors with histologic or genetic overlap. Copy number variation analysis showed a flat copy number profile in 3 cases and chr9p arm-level copy number loss in the case with necrosis and mitotic activity. All patients underwent complete excision; no recurrences or metastases were observed over a limited follow-up period (available in 4 cases, range, 8-24 months; median, 10.5 months). In conclusion, ZFTA::NCOA1/2-rearranged epithelioid mesenchymal tumors represent a novel, morphologically distinct entity, genetically and epigenetically overlapping with chondroid lipoma. Expanded cohorts and long-term follow-up are necessary to clarify their precise classification and biologic behavior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio.
- Department of Internal Medicine II, Medical Oncology, University Hospital Würzburg, Würzburg, Germany; National Center for Tumor Diseases WERA, Würzburg, Germany.
- Dr Senckenberg Institute of Pathology, University Hospital Frankfurt of the Goethe University Frankfurt, Frankfurt, Germany.
- Division of Translational Medical Oncology, German Cancer Research Center, Heidelberg, Germany; National Center for Tumor Diseases Heidelberg, Heidelberg, Germany.
- Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen.
- Biopticka Laboratory Ltd., Pilsen, Czech Republic; Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic.
Förderung
- U.S. Department of Defense
- Cleveland Clinic
- European Commission
Zitieren
APA
Rizwan, R., Venkataramani, V., Haug, L., Hattery, T., Chen, M., Nakitandwe, J., Shurtleff, S., Azzato, E. M., Teleanu, M. V., Hüllein, J., Fröhling, S., Stoehr, R., Billings, S. D., Michal, M., Fritchie, K. J., Agaimy, A., & Dermawan, J. K. (2026). ZFTA::NCOA1/2-Rearranged Epithelioid Mesenchymal Tumor—A Phenotypically Distinct Myoepithelial-Like Neoplasm Epigenetically Overlapping With Chondroid Lipoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100939
Vancouver
Rizwan R, Venkataramani V, Haug L, Hattery T, Chen M, Nakitandwe J, et al. ZFTA::NCOA1/2-Rearranged Epithelioid Mesenchymal Tumor—A Phenotypically Distinct Myoepithelial-Like Neoplasm Epigenetically Overlapping With Chondroid Lipoma. Modern Pathology. 2026. doi:10.1016/j.modpat.2025.100939
BibTeX
@article{Rizwan2026,
author = {Rizwan, Raheel and Venkataramani, Vivek and Haug, Lukas and Hattery, Travis and Chen, Mark and Nakitandwe, Joy and Shurtleff, Sheila and Azzato, Elizabeth M and Teleanu, Maria-Veronica and Hüllein, Jennifer and Fröhling, Stefan and Stoehr, Robert and Billings, Steven D and Michal, Michael and Fritchie, Karen J and Agaimy, Abbas and Dermawan, Josephine K},
title = {ZFTA::NCOA1/2-Rearranged Epithelioid Mesenchymal Tumor—A Phenotypically Distinct Myoepithelial-Like Neoplasm Epigenetically Overlapping With Chondroid Lipoma},
journal = {Modern Pathology},
year = {2026},
doi = {10.1016/j.modpat.2025.100939}
}
EUVIMED